Finance

Lists
1099:HKG
Sinopharm Group Co Ltd
HK$ 15.72
+0.45%
(+0.070) 1D
10-р сарын 16, 16:08:14 (GMT+8)  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1099...
Open
HK$ 15.79
High
HK$ 15.99
Low
HK$ 15.67
Mkt. cap
49.06 тэрбум
Avg. vol.
4.85 сая
Volume
5.89 сая
Dividend
5.03%
Quarterly dividend
HK$ 0.20
Ex-dividend date
2026 оны 6-р сарын 23
P/E ratio
5.90
52-wk high
HK$ 22.34
52-wk low
HK$ 14.55
EPS
HK$ 2.67
Shares outstanding
1.19 тэрбум
No. of employees
90 мян
Open
HK$ 15.79
High
HK$ 15.99
Low
HK$ 15.67
Mkt. cap
49.06 тэрбум
Avg. vol.
4.85 сая
Volume
5.89 сая
Dividend
5.03%
Quarterly dividend
HK$ 0.20
Ex-dividend date
2026 оны 6-р сарын 23
P/E ratio
5.90
52-wk high
HK$ 22.34
52-wk low
HK$ 14.55
EPS
HK$ 2.67
Shares outstanding
1.19 тэрбум
No. of employees
90 мян
News stories
From web sources and news partners
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group Co Ltd
CEO-
Employees90.4 мян
Founded2003
Headquarters-
SectorHealth care provider
Last report
2026 оны 8-р сарын 24
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
142.03Т / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
145.44Т
143.69Т
140.77Т
142.03Т
Cost of goods sold
134.52Т
133.28Т
131.40Т
132.33Т
Cost of revenue
134.52Т
133.28Т
131.40Т
132.33Т
Research and development expenses
172.61 сая
-172.61 сая
46.59 сая
-46.59 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.17 тэрбум
7.34 тэрбум
5.10 тэрбум
5.70 тэрбум
Operating expense
6.80 тэрбум
5.00 тэрбум
6.29 тэрбум
5.45 тэрбум
Total operating expenses
141.32Т
138.29Т
137.69Т
137.78Т
Operating income
4.12 тэрбум
5.40 тэрбум
3.07 тэрбум
4.26 тэрбум
Other non operating income
120.78 сая
-427.44 сая
39.60 сая
-100.78 сая
EBT including unusual items
3.67 тэрбум
3.92 тэрбум
2.90 тэрбум
4.05 тэрбум
EBT excluding unusual items
3.51 тэрбум
5.36 тэрбум
2.90 тэрбум
4.25 тэрбум
Income tax expense
905.42 сая
1.19 тэрбум
712.28 сая
1.05 тэрбум
Effective tax rate
24.66%
30.30%
24.57%
26.02%
Other operating expenses
917.07 сая
-1.10 тэрбум
204.49 сая
-392.73 сая
Net income
1.84 тэрбум
1.85 тэрбум
1.41 тэрбум
1.99 тэрбум
Net profit margin
1.27%
1.29%
1.00%
1.40%
Earnings per share
-
-
-
-
Interest and investment income
364.24 сая
-
171.27 сая
-
Interest expense
-412.56 сая
-846.59 сая
-383.82 сая
-505.78 сая
Net interest expenses
-48.32 сая
-846.59 сая
-212.55 сая
-505.78 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
4.66 тэрбум
5.91 тэрбум
3.58 тэрбум
4.78 тэрбум
Gain or loss from assets sale
11.79 сая
-20.53 сая
-
-14.32 сая
AI content may include mistakes. Learn more
Google аппс